Solid state differentiation of plasma thiols using a centrifugally activated mercaptobenzothiazole disulfide exchange indicator by Chahine, S et al.
CREATED USING THE RSC COMMUNICATION TEMPLATE (VER. 2.1) - SEE WWW.RSC.ORG/ELECTRONICFILES FOR DETAILS 
COMMUNICATION www.rsc.org/[journal] | [journal name] 
Solid State Differentiation of Plasma Thiols using a Centrifugally 
Activated Mercaptobenzothiazole Disulphide Exchange Indicator 
Samir Chahine,a Callum Livingstone,b and James Davis*a 
Receipt/Acceptance Data [DO NOT ALTER/DELETE THIS TEXT] 
Publication data [DO NOT ALTER/DELETE THIS TEXT] 5 
10 
15 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
70 
75 
80 
85 
90 
DOI: 10.1039/b000000x [DO NOT ALTER/DELETE THIS TEXT] 
The solid state interaction of mono and macromolecular thiols at 
a disulphide heterocycle is shown to provide a versatile pathway 
for their speciation. 
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 The concentration of anti-oxidant thiol (RSH) within plasma has 
been shown to be a potentially valuable semi-quantitative indicator 
through which the severity of various injuries or diseases can be 
assessed1-6. While Ellmans Reagent (5,5’-dithio-(2-nitrobenzoic 
acid))7 has long been the mainstay of routine thiol analysis, it is 
unable to speciate between sulphydryl albumin and the low, mono-
molecular species such as glutathione (GSH), cysteine (CSH) and 
homocysteine (HCSH) and, as a consequence, can only deliver 
total plasma thiol (PSH) concentration. The latter is widely 
recognized as having clinical merit4 but there is considerable debate 
as to whether mono, macro or total thiol respond in equal measure 
to the onset of physiological stress4-6, 8-10. The ability to differentiate 
between the different components invariably requires more 
elaborate liquid chromatographic analysis and hence requires the 
referral of the sample to specialist laboratories with the time delays 
often negating the diagnostic advantage. The present 
communication presents a wholly new but integrated strategy for 
plasma thiol analysis that provides the clinician with ready access 
to a procedure that could distinguish between these groups. This 
could thereby offer the possibility of facilitating a better 
understanding of the PSH/RSH metabolomics.  
 The basic strategy is outlined in figure 1 and is highlighted by 
the passage of cysteine (I) through  a centrifugal filter packed with 
a 2,2’-dithio(bis)benzothiazole (II) indicator. The latter is insoluble 
within aqueous solution and serves as a densely packed particulate 
filter. In principle, the disulphide should react with free sulphydryl 
thiols through a mechanism analogous to that observed with 
Ellman’s Reagent (ER) resulting in the formation of the mixed 
disulphide (III) and the release of the mercaptobenzothiazole anion 
(IV). 
 Spectroscopic investigation (uv/vis and 1H NMR) of the filtrate 
revealed that the principal product in the filtrate was in fact the 
mixed disulphide(III) and not the free mercaptobenzothiazole (IV). 
It appears that the latter, like its disulphide parent, is insoluble 
within the buffer and is retained within the packing material. The 
addition of the amino acid functionality to the complementary 
thiazole component serves to aid solubilisation and, as such, is 
preferentially released. Similar results were obtained for 
homocysteine and glutathione.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. Centrifugal Filter Device (CFD)   
 
 An assessment of the percentage conversion of the free thiol into 
the mercaptobenzothiazole (MBT) conjugate was conducted 
(employing a before and after spectroscopic methodology) with the 
recovery of the thiol constituents being in order of 100 +/- 2 % 
(based on 20 μM cysteine). The uv spectroscopic profiles for 
additions of CSH (40 μM), GSH (40 μM) and bovine albumin 
(0.82 mg/L) are shown in figure 2.  The principal absorption bands 
for CSH, GSH and HCSH moieties were observed at 312nm and 
correspond predominately to the MBT component of the 
conjugates. Significantly, the passage of albumin did not lead to 
any change in the absorption profile from that of the corresponding 
unfiltered control. 
 The molar absorptivities (CSH, λmax = 312nm, ε = 275 mol-1 L 
cm-1 and GSH, ε = 365 mol-1 L cm-1) are significantly less than that  
of ER (λmax = 412nm, ε = 14150 mol-1 L cm-1) and can be 
attributed to the lack of the nitrothiolate chromophore. It can be 
inferred that the added complexity of the proposed procedure and 
poor sensitivity would fail to make this a realistic competitor to 
existing spectroscopic protocols. However, the prime advantage 
lies in the interaction of the thiol component with the particulate 
packing. As 2,2’-dithio(bis)benzothiazole is essentially insoluble, 
the exchange is dependent upon the target reacting directly with the 
lid packing as it is forced through the filter. The key question in so
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the present investigation revolved around whether sterically buried 
thiol functionalities, ie those within albumin, were capable of 
interacting with the solid. While such groups are accessible to 
freely diffusible derivatisation agents such as ER, it could be 
anticipated that the protein shield would prevent the intimate and 
specific contact required for reaction in the present case. The assay 
could therefore allow a specificity, as yet, unattainable using 
conventional wet chemical techniques. 
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Fig 2.  Spectroscopic profiles of CFD processed MBT conjugates compared 
with that of an albumin sample. 
 
 The absence of the MBT spectroscopic profile from the CFD 
processed albumin, figure 2, would suggest that the protein did not 
react. This preliminary result was followed up by passing a series 
of albumin solutions (0.02 to 0.82 mg/L) through the modified 
filter with the filtrates analysed for thiol through the addition of ER. 
In contrast to the previous experiments with the monomolecular 
thiols, positive results were obtained. The recovery of ER active 
albumin was typically 100 +/- 1 % (RSD = 1.5 %, N = 3 based on 
0.82 mg/L AlbSH) and serves to confirm our supposition that direct 
and specific interaction at the solid interface is required for 
disulphide exchange to occur.  
 The clinical efficacy of the system for discriminating between 
albumin, low molecular weight thiols and indeed other 
physiological components was then assessed through examining 
the plasma thiol profiles of three individuals (2M, 1F). Plasma 
samples (500 uL) were passed directly through the filter without 
any form of pretreatment. The filtrate was first analysed using 
direct uv spectroscopic analysis as indicated previously (figure 2). 
The absence of any appreciable absorbance within the plasma at 
312nm should therefore allow any increase at this wavelength, 
subsequent to CFD processing, to be attributed predominantly to 
the presence of MBT conjugates. The magnitude of the latter 
providing an immediate estimation of low molecular weight thiol 
concentration. However, there is an inherent limitation to this 
approach in that the spectroscopic properties of the conjugate will 
differ depending on the nature of the amino acid substituent. This is 
evident from the molar absorptivity data presented previously for 
the GSH, CSH and HCSH variants. The data obtained is presented 
in table 1 and was analysed using the regression data from both 
GSH and CYS calibration runs, the difference between the two 
estimates in practice have a negligible bearing on the measurement 
with the differing determinations of total low molecular weigh
th
 
 
 
 
 
 
 
 
 
 
 
 A series of secondary experiments were then conducted using 
ER before and after the passage of plasma through the modified 
filter device.  The results are detailed in table 2. Ellman analysis of 
the plasma before filtration yields the total plasma thiol 
concentration (PSH) with the subsequent filtrate providing 
albuminSH - given that the low molecular weight specie
T conj
 
 
 
 
 
 
 
 
 
 
 
 
 
 It can be assumed that the subtraction of the albuminSH from 
the PSH result should yield the low molecular weight thiol 
concentration. The estimates shown in table 2 are in excellent 
agreement with the direct uv spectroscopic determination.  This 
again confirms that, despite the minor variation in uv/vis sensitivity 
between different
clinically robust. 
 It could be anticipated that chemical manipulation of the 
disulphide to incorporate a chromophore (such as the nitro group 
common to ER) or an electro-responsive redox substituent would 
provide a significant enhancement to the basic assay performance. 
The use of quinoid indicators to facilitate potentiometric detection 
– essentially acting as an electrochemical Ellmans test - is also 
possible with the filter packing providing the all impor
differentiation between macro and mono molecular thiols10,11.  
 The system also provides an effective means through which 
albumin can be assessed as this is increasingly being viewed as an 
important diagnostic in its own right8-10. The standard adsorptive 
dye methodologies such as bromocresol green (BCG) assays that 
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are currently used can be subject to interference13-16 and hence the 
approach advocated here could allow a more robust route to 
analysis. The clinical viability of the latter was assessed and the 
results obtained from the centrifugal system compared with the 
BCG test. The preliminary results are detailed in table 3 and show a 200 
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 The system is clearly a vesratile assay that can be used to effect 
the speedy, accessible, and accurate speciation of physiologically 
significant thiol groupings. It can thus aid the differentiation 
between mono and macromolecular species and provides distinct 
routes through which both can be easily quantified. The system is  
readily attainable and provides a simple route through which a key 
clinical need could be addressed. The solid state differentiation 
capabilities presented by the disulphide could also be exploited in a 
variety of other formats and is not limited solely to the centrifugal 
separation exploited here. It could serve as an selective coating in 
sensors or a pre or post column derivatising step in LC applications. 
It is clear however that the protocol presented thus far provides a 
novel, robust and gener
c
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